AMGN PEER ANALYSIS

Amgen Inc — metric-by-metric comparison with peers and the industry median

AMGNAmgen Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

AMGNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AMGN	SAN	BAYN	AZN	GRF	Ind. Median
P/E	25.67	8.81●	—	29.06	14.83	22.24
P/B	21.79	1.25	1.73	6.38	1.13●	4.57
EV/EBITDA	14.71	9.71●	23.43	16.09	10.52	13.69
P/S	5.38	1.96	1.10	5.00	0.83●	3.10

Financial Health
Metric	AMGN	SAN	BAYN	AZN	GRF	Ind. Median
Current Ratio	1.26	1.01	1.06	0.91	2.47●	1.25
Debt/Equity	623.8%	27.5%●	134.8%	71.7%	177.2%	94.3%
NetDebt/EBITDA	2.71	1.33	9.19	1.29●	6.22	1.35

Profitability
Metric	AMGN	SAN	BAYN	AZN	GRF	Ind. Median
Net Margin	20.9%	22.3%●	-4.8%	17.2%	5.6%	15.0%
ROE	101.3%●	14.1%	-7.0%	23.5%	7.5%	23.7%
ROA	8.6%	8.0%	-2.0%	9.4%●	2.0%	8.0%
EBITDA Margin	44.8%●	23.4%	7.7%	33.7%	19.3%	28.4%

Growth + Dividend
Metric	AMGN	SAN	BAYN	AZN	GRF	Ind. Median
Rev. Growth	9.1%	3.3%	-2.9%	9.9%●	0.9%	3.3%
NI Growth	31.5%	59.8%	—	33.7%	112.7%●	32.9%
Div. Yield	2.7%●	0.0%	0.2%	0.2%	2.1%	2.1%
Payout	66.7%	0.0%	-5.9%	47.3%	30.8%	45.7%

Valuation
Metric	AMGN	GILD	PFE	MRK	BMY	ABBV	Ind. Median
P/E	25.67	18.55	18.41	35.65	16.28●	124.14	22.24
P/B	21.79	7.27	1.53	6.94	5.90	-68.32●	4.57
EV/EBITDA	14.71	12.66	11.30	19.27	11.09●	30.45	13.69
P/S	5.38	5.75	2.18●	4.86	2.44	7.19	3.10

Financial Health
Metric	AMGN	GILD	PFE	MRK	BMY	ABBV	Ind. Median
Current Ratio	1.26	1.97●	1.25	1.30	1.42	0.80	1.25
Debt/Equity	623.8%	94.3%	71.5%	107.1%	221.5%	-1,101.9%●	94.3%
NetDebt/EBITDA	2.71	0.85●	3.07	2.31	2.47	3.75	1.35

Profitability
Metric	AMGN	GILD	PFE	MRK	BMY	ABBV	Ind. Median
Net Margin	20.9%	31.0%●	11.8%	13.6%	15.0%	5.8%	15.0%
ROE	101.3%●	43.2%	8.3%	19.0%	38.8%	—	23.7%
ROA	8.6%	16.4%●	3.6%	7.3%	8.1%	2.7%	8.0%
EBITDA Margin	44.8%	48.7%●	26.5%	28.6%	28.4%	26.9%	28.4%

Growth + Dividend
Metric	AMGN	GILD	PFE	MRK	BMY	ABBV	Ind. Median
Rev. Growth	9.1%	3.5%	1.4%	2.5%	1.8%	9.5%●	3.3%
NI Growth	31.5%	54.5%●	-4.8%	-48.7%	34.2%	-13.3%	32.9%
Div. Yield	2.7%	2.5%	7.2%●	2.6%	4.5%	2.7%	2.1%
Payout	66.7%	43.8%	130.5%	92.1%	69.7%	324.8%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AMGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.